Related Articles
Combination of lenalidomide and low-dose dexamethasone therapy promotes the anticoagulant activity of warfarin in patients with immunoglobulin light-chain amyloidosis
Evidence-based study on antithrombotic therapy in patients at risk of a stroke with paroxysmal atrial fibrillation
Analysis of the first therapeutic-target-achieving time of warfarin therapy and associated factors in patients with pulmonary embolism
Clinical application of a new warfarin-dosing regimen based on the CYP2C9 and VKORC1 genotypes in atrial fibrillation patients
Clinical verification of Lou type warfarin pharmacokinetic dosing algorithms equation